The Covid-19 crisis has shown that we need to find other ways of measuring national success than just GDP, Robeco’s sustainability experts say.
The pandemic caused massive falls in Gross Domestic Product (GDP) as governments around the world introduced lockdowns and social distancing measures to curtail the coronavirus. In doing so, they were saving lives and protecting well-being – a measure that is not properly reflected in GDP calculations.
In a new paper, Jacob Messina, RobecoSAM’s Senior Sustainable Investing Strategist, and Jan Anton van Zanten, Robeco Strategist for the Sustainable Development Goals, argue that alternatives should be used rather than the blunt instrument of GDP.
They discuss the macroeconomic picture down to the microeconomic implications for investors, suggesting that new solutions that monetize the key drivers of health and well-being are needed to align the financial incentives of investors with their sustainability objectives. The end result is a better understanding of value creation and a shift in how we allocate capital.
“The principal problem with using GDP is its failure to capture a myriad of externalized costs and benefits, many of which mean the difference between life and death,” the authors say in their report. “For example, the production and consumption of cigarettes, sugary drinks and fast food all inflate GDP. However, the adverse health impacts they inflict on their consumers is insufficiently captured by the metric, and are thus easily ignored.”
“By the same reasoning, GDP measures the incomes (salaries, profits, taxes) from essential services such as health and education, but fails to adequately measure all the societal benefits that these activities provide to society in the long run. These shortcomings make investing in a sustainable future less attractive from a GDP perspective.”
“Environmental stewardship, in turn, typically reduces GDP, because it does not include the value that nature provides. Healthy ecosystems and biodiversity provide numerous services, from pollination and clean drinking water to medicinal resources and recreation. Hence, nature provides the essentials for a high quality of life.”
The Covid-19 crisis has also exposed problems and perceptions with how we value so-called ‘low-value’ professions such as nurses, the authors say.
“We see that many jobs at the frontline of battling the pandemic – from nurses and caregivers to cashiers and warehouse workers – receive relatively low wages. While GDP only measures these professionals’ contribution to society by looking at their income, their societal impact is of course much greater: they protect people’s health and well-being and sustain us.”
“In other words, GDP calculations assume that price equates to value, when this is often not the case.”
Countries are experimenting with alternatives to GDP. “One example is the Well-being Economy Governments (WEGo) partnership of nations including New Zealand and Scotland that aim to focus more on how healthy rather than wealthy their societies are becoming.”
And in developing such alternatives, science plays a key role. “We see that scientific concepts for measuring social well-being and ecological sustainability are now turning into practical frameworks,” the authors say.
“The concept of ‘doughnut economics’, for example, gained wide traction in recent years. This doughnut seeks to simultaneously ensure that people’s well-being is met through twelve social dimensions, while the environmental limits of our planet are not exceeded through quantifying the nine planetary boundaries.”
Robeco measures the various impacts of its investments using economic, social and environmental (ESG) indicators. Examples include the number of clean gigawatts per hour of energy provided and the amount of greenhouse gas emissions that were avoided in the RobecoSAM Smart Energy strategy, or the volumes of waste recycled and avoided in the Smart Materials strategy.
However, standardization across the industry is lacking. Robeco is working with others in the industry to share knowledge and develop impact standards. An example is the Natural Capital Declaration, an initiative led by the United Nations Environment Programme Finance Initiative and the Global Canopy Program, that helps the financial sector to integrate natural capital considerations into investment products, as well as in accounting, disclosure and reporting frameworks.
“Developing better metrics and integrating these into investment processes is a journey that we embarked on, together with peers and research institutes, that requires continuous improvement and development,” the authors say. “While we have not (yet) found the ‘holy grail’, we increasingly improve our assessment on investments’ economic, social, and environmental impacts.”
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.